retatrutide effects clinical trial Retatrutide—A Game Changer in Obesity Pharmacotherapy Retatrutide vs Tirzepatide: GLP-1, GIP

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

In research settings, Retatrutide is typically framed not simply as another incretin mimetic peptide, but as a mechanistic probe for tri-agonist biology

Important Safety Note: GLP-1 medications are strictly contraindicated (must not be used) if you have a personal or family history of Medullary Thyroid Cancer (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Perdomo CM, Cohen RV, Sumithran P, Clment K, Frhbeck G

WHY CHOOSE MILWAUKEE LASER & BODY AESTHETICS

You're self-experimenting with an unapproved drug